Fastly (NYSE:FSLY) shares slipped fractionally in premarket trading on Thursday, even as investment firm Piper Sandler upped ...

Don Schneider, Piper Sandler deputy head of U.S. policy, joins CNBC's 'The Exchange' to discuss portfolio positioning ahead ...

Piper Sandler raises Fastly target to $8; keeps Neutral rating. Fastly's Q3 EPS beats estimates, revenue slightly misses ...

In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Solid Biosciences (SLDB – Research Report), with a ...

Piper Sandler (PIPR) and BC Partners Credit, the $8B credit arm of investment firm BC Partners, announced a strategic alliance. “The ...

Boston Beer (NYSE:SAM – Free Report) had its price objective boosted by Piper Sandler from $325.00 to $330.00 in a research ...

Operator: Good morning. And welcome to the Piper Sandler Companies’ Third Quarter 2024 Earnings Conference Call.

On Monday, Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.63 which represents a slight increase of $0.04 or 2.52% from the prior close of $1.59. The stock opened at $1.

Piper Sandler also addresses the intersection of momentum with quality stocks. They emphasize that quality strategies, which ...

Boston Beer Company sees increased analyst confidence after Q3 results, driven by strong margin control and growth potential, despite ongoing volume challenges.

On Tuesday, Piper Sandler began coverage on Upstream Bio (NASDAQ:UPB) stock, assigning an Overweight rating and setting a price target of $75.00. The firm highlighted the potential of Upstream Bio's ...

NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Piper Sandler Companies (NYSE: PIPR), a leading investment bank, and BC Partners Credit, the $8 billion credit arm of international investment firm BC ...